TRCT
SGTX

Tower Research Capital (TRC)’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,069
Closed -$46.6K – 6508
2023
Q2 		$46.6K Buy
2,069
+1,037
+100% +$7.53K ﹤0.01% 2642
2023
Q1 		$12K Buy
1,032
+92
+10% +$956 ﹤0.01% 4165
2022
Q4 		$4K Sell
940
-41
-4% -$234 ﹤0.01% 5129
2022
Q3 		$6K Buy
981
+705
+255% +$6.44K ﹤0.01% 5100
2022
Q2 		$3K Sell
276
-445
-62% -$5.98K ﹤0.01% 5461
2022
Q1 		$14K Buy
721
+436
+153% +$9.71K ﹤0.01% 3938
2021
Q4 		$10K Sell
285
-64
-18% -$3.64K ﹤0.01% 4644
2021
Q3 		$26K Buy
349
+252
+260% +$19.4K ﹤0.01% 3501
2021
Q2 		$13K Buy
97
+33
+52% +$5.8K ﹤0.01% 4254
2021
Q1 		$19K Buy
+64
New +$25.4K ﹤0.01% 3943

Other funds holding SGTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s SGTX Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 2,069 shares — an estimated $46.6K sold.

Tower Research Capital (TRC) first reported a position in SGTX in Q1 2021 and held it in 10 quarters. The position peaked at $46.6K in Q2 2023. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,069 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $46.6K.
  • Tower Research Capital (TRC) first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Sigilon Therapeutics, Inc. Common Stock position peaked at $46.6K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.